O2matic has in March 2025 both received MDR certification and granted a patent.

This milestone underscores our commitment to delivering the highest standard of medical device safety and performance for automated oxygen therapy.

With the MDR certification for our Quality Management System and our patent, we continue to lead the way in innovative, patient-centric solutions that enhance respiratory care, ensuring both quality and compliance with the latest EU regulations 🇪🇺

A huge thank you to our dedicated team, partners, and customers who have supported us on this journey.

This is just the beginning!
We are excited about the future and look forward to continuing our mission to improve patient care and outcomes with cutting-edge technology